Jin Bo
Sep 17, 2010

Tissue brand Mayflower appoints Vizeum to handle media business

SHANGHAI – Vizeum, Aegis Media’ international service network, has announced that its Shanghai office has been appointed to handle integrated media for tissue brand Mayflower in East China this year.

Tissue brand Mayflower appoints Vizeum to handle media business

The agency will be responsible for media planning, media strategy and TV buying.

Mayflower, a brand owned by Taiwan paper giant YFY, was introduced to mainland consumers in 1993. Its success was soon replicated in Taiwan where it has long been a market leader.

Commenting on the appointment, YFY said it was deeply impressed with Vizeum's unique insights of the market and efficiency, adding that the agency's professional service and competitive price were the major reasons that led to the partnership.

Earlier this week, Vizeum announced winning media duties for Chinese frozen food maker Sanquan following a three way pitch.

Source:
Campaign China

Follow us

Top news, insights and analysis every weekday

Sign up for Campaign Bulletins

Related Articles

Just Published

1 day ago

Alibaba pledges 'aggressive' AI investment, reports ...

Revenue jumped 8% as Alibaba's AI-driven strategy paid off. A surge in investor confidence has sent its share price soaring over 60% since the start of the year.

1 day ago

Five by Five Global to deliver AI-powered campaigns ...

Can creativity truly be compressed? Former Cheil Australia MD Mark Anderson, now at Five by Five Global, is betting big on AI with a new seven-hour sprint model to find out.

1 day ago

BBDO launches new global vision to focus on bolder ...

'Do Big Things' will empower brands to take risks, make noise, and tackle the world's biggest problems with bold solutions, says global CEO Nancy Reyes.

1 day ago

Is Elon Musk’s X winning back advertisers?

Social media platform X is reportedly in talks to raise money at its buying price valuation of $44 billion, despite user and advertiser losses since Elon Musk’s acquisition in 2022.